首页> 外文期刊>Cytotechnology >An arthroscopic approach for the treatment of osteochondral focal defects with cell-free and cell-loaded PLGA scaffolds in sheep
【24h】

An arthroscopic approach for the treatment of osteochondral focal defects with cell-free and cell-loaded PLGA scaffolds in sheep

机译:关节镜下用无细胞和载有细胞的PLGA支架治疗骨软骨局灶性缺损的方法

获取原文
获取外文期刊封面目录资料

摘要

Osteochondral injuries are common in humans and are relatively difficult to manage with current treatment options. The combination of novel biomaterials and expanded progenitor or stem cells provides a source of therapeutic and immunologically compatible medicines that can be used in regenerative medicine. However, such new medicinal products need to be tested in translational animal models using the intended route of administration in humans and the intended delivery device. In this study, we evaluated the feasibility of an arthroscopic approach for the implantation of biocompatible copolymeric poly-d,l-lactide-co-glycolide (PLGA) scaffolds in an ovine preclinical model of knee osteochondral defects. Moreover this procedure was further tested using ex vivo expanded autologous chondrocytes derived from cartilaginous tissue, which were loaded in PLGA scaffolds and their potential to generate hyaline cartilage was evaluated. All scaffolds were successfully implanted arthroscopically and the clinical evolution of the animals was followed by non invasive MRI techniques, similar to the standard in human clinical practice. No clinical complications occurred after the transplantation procedures in any of the animals. Interestingly, the macroscopic evaluation demonstrated significant improvement after treatment with scaffolds loaded with cells compared to untreated controls.
机译:骨软骨损伤在人类中很常见,并且在当前的治疗方案中相对难以控制。新型生物材料与扩增的祖细胞或干细胞的结合提供了可用于再生医学的治疗和免疫相容药物的来源。然而,需要使用预期的人类给药途径和预期的递送装置在转化动物模型中测试这种新的医药产品。在这项研究中,我们评估了在羊膝软骨缺损的临床前模型中植入生物相容性共聚聚-d,l-丙交酯-共-乙交酯(PLGA)支架的关节镜方法的可行性。此外,使用源自软骨组织的离体扩增自体软骨细胞进一步测试了该程序,将其加载到PLGA支架中并评估其产生透明软骨的潜力。所有支架均成功地通过关节镜植入,并通过无创MRI技术跟踪动物的临床发展,类似于人类临床实践中的标准。在任何动物中,移植手术后均未发生临床并发症。有趣的是,与未处理的对照相比,宏观评估显示了在用装有细胞的支架处理后的显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号